Long term outcome after conservative and surgical treatment of haemorrhagic moyamoya disease

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 84, Issue 3, 2013, Pages 258-265

  Liu, Xingju ^a   Zhang, Dong ^a   Shuo, Wang ^a   Zhao, Yuanli ^a   Wang, Rong ^a   Zhao, Jizong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLEEDING; CHILD; CONSERVATIVE TREATMENT; DIGITAL SUBTRACTION ANGIOGRAPHY; FEMALE; FOLLOW UP; HUMAN; MALE; MEDICAL RECORD REVIEW; MOYAMOYA DISEASE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; REVASCULARIZATION; RISK ASSESSMENT; SCHOOL CHILD;

EID: 84874117747     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2012-302236     Document Type: Article

References (27)

1. Suzuki J, Kodama N. Moyamoya diseaseda review. Stroke 1983; 14:104e9.
2. Han DH, Kwon OK, Byun B.J., et al A co-operative study: clinical characteristics of 334 Korean patients with moyamoya disease treated at neurosurgical institutes (1976e1994). Acta Neurochir (Wien) 2000; 142:1263e74.
3. Scott RM, Smith JL, Robertson R.L., et al Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg 2004; 100:142e9.
4. Mesiwala AH, Sviri G, Fatemi N., et al Long-term outcome of superficial temporal arteryemiddle cerebral artery bypass for patients with moyamoya disease in the US. Neurosurg Focus 2008; 24:E15.
5. Matsushima T, Inoue T, Suzuki S.O., et al Surgical treatment of moyamoya disease in pediatric patients, comparison between the results of indirect and direct revascularization procedures. Neurosurgery 1992; 31:401e5.
6. Kawaguchi S, Okuno S, Sakaki T. Effect of direct bypass on the prevention of future stroke in patients with the hemorrhagic variety of moyamoya disease. J Neurosurg 2000; 93:397e401.
7. Fujii K, Ikezaki K, Irikura K., et al The efficacy of bypass surgery for patients with hemorrhagic moyamoya disease. Clin Neurol Neurosurg 1997; 99:194e5.
8. Kobayashi E, Saeki N, Oishi H., et al Long-term natural history of hemorrhagic moyamoya disease in 42 patients. J Neurosurg 2000; 93:976e80.
9. Kikuta K, Takagi Y, Nozaki K., et al The presence of multiple microbleeds as a predictor of subsequent cerebral hemorrhage in patients with moyamoya disease. Neurosurgery 2008; 62:104e11.
10. Yoshida Y, Yoshimoto T, Shirane R., et al Clinical course, surgical management, and long-term outcome of moyamoya patients with rebleeding after an episode of intracerebral hemorrhage: an extensive follow-up study. Stroke 1999; 30:2272e6.
11. Suzuki J, Takaku A, Asahi M. Evaluation of a group of disorders showing an abnormal vascular network at the base of the brain with a high incidence among the Japanese. No To Shinkei 1966; 18:897e908.
12. Duan L, Bao XY, Yang W.Z., et al Moyamoya disease in China: its clinical features and outcomes. Stroke 2012; 43:56e60.
13. Miao W, Zhao PL, Zhang Y.S., et al Epidemiological and clinical features of moyamoya disease in Nanjing, China. Clin Neurol Neurosurg 2010; 112:199e203.
14. Christopher L, Keith M, Robert L., et al Clinical features and outcome in North American adults with moyamoya phenomenon. Stroke 2006; 37:1490e6.
15. Kraemer M, Heienbrok W, Berlit P. Moyamoya disease in Europeans. Stroke 2008; 39:3193e200.
16. Yamashita M, Oka K, Tanaka K. Histopathology of the brain vascular network in moyamoya disease. Stroke 1983; 14:50e8.
17. Kwak R, Ito S, Yamamoto N., et al Significance of intracranial aneurysms associated with moyamoya disease. Neurol Med Chir (Tokyo) 1984; 24:97e103.
18. Ikezaki K, Fukui M, Inamura T., et al The current status of the treatment for hemorrhagic type moyamoya disease based on a 1995 nationwide survey in Japan. Clin Neurol Neurosurg 1997; 2:183e6.
19. Morioka M, Hamada J, Todaka T., et al High-risk age for rebleeding in patients with hemorrhagic moyamoya disease: long-term follow-up study. Neurosurgery 2003; 52:1049e54.
20. Iwama T, Morimoto M, Hashimoto N., et al Mechanism of intracranial rebleeding in moyamoya disease. Clin Neurol Neurosurg 1997; 2:187e90.
21. Houkin K, Kamiyama H, Abe H., et al Surgical therapy for adult moyamoya disease: can surgical revascularization prevent the recurrence of intracranial hemorrhage? Stroke 1996; 27:1342e6.
22. Okada Y, Shima T, Nishida M., et al Effectiveness of superficial temporal arteryemiddle cerebral artery anastomosis in adult moyamoya disease: cerebral hemodynamics and clinical course in ischemic and hemorrhagic varieties. Stroke 1998; 29:625e30.
23. Fujimura M, Mugikura S, Kaneta T., et al Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease. Surg Neurol 2008; 71:223e7.
24. Kim DS, Kang SG, Yoo D.S., et al Surgical results in pediatric moyamoya disease: angiographic revascularization and the clinical results. Clin Neurol Neurosurg 2007; 109:125e31.
25. Jin SC, Oh CW, Kwon O.K., et al Epilepsy after bypass surgery in adult moyamoya disease. Neurosurgery 2011; 68:1227e32.
26. Zipfel GJ, Fox DJ Jr, Rivet DJ Moyamoya disease in adults: the role of cerebral revascularization. Skull Base 2005; 15:27e41.
27. Houkin K, Nakayama N, Kuroda S., et al How does angiogenesis develop in pediatric moyamoya disease after surgery? A prospective study with MR angiography. Childs Nerv Syst 2004; 20:734e41.